Removing the Bottlenecks from Glycosylation Analysis

High-Throughput Glycan Analysis in Biopharmaceuticals | SCIEX & Sanofi Collaboration Streamline your biopharmaceutical development with high-throughput glycan analysis solutions from SCIEX, designed in collaboration with Sanofi. Glycosylation plays a crucial role in the safety, efficacy, and stability of therapeutic proteins. As such, rapid, accurate, and reliable glycan analysis is essential for maintaining biopharmaceutical product quality. SCIEX offers innovative technology that enables robust glycan profiling through high-performance capillary electrophoresis (CE) systems and LC-MS (liquid chromatography-mass spectrometry) methods. Our powerful, high-throughput glycan analysis workflows enhance speed and precision, allowing biopharma companies to accelerate drug development, reduce costs, and meet regulatory requirements. In this video, you’ll see how Sanofi integrates SCIEX's advanced solutions into their workflow, achieving optimized glycan characterization and improving the quality and consistency of biologics. SCIEX's technologies help to streamline glycan analysis, providing comprehensive glycan profiles with high sensitivity and throughput. By leveraging these state-of-the-art tools, biopharma companies can confidently meet the challenges of complex glycan analysis in drug development. Discover how SCIEX and Sanofi are revolutionizing glycan analysis for the biopharma industry. Whether you're involved in drug discovery, development, or quality control, SCIEX offers the tools and expertise you need to enhance your biopharmaceutical workflows. Keywords: Glycan analysis, high-throughput, biopharmaceuticals, glycosylation, SCIEX, Sanofi, capillary electrophoresis, CE, LC-MS, drug development, biologics, glycan profiling, protein therapeutics.